Target will report its earnings before the bell. Here's what to expect

Target will report its earnings before the bell. Here's what to expect


The Target logo is seen on its store on 42nd Street in Times Square, New York City.

Deb Cohn-Orbach | UCG | Universal Images Group | Getty Images

Target will report its holiday-quarter results and year-ahead outlook on Tuesday.

Here’s what Wall Street analysts surveyed by LSEG, formerly known as Refinitiv, are expecting for the company’s fourth quarter:

  • Earnings per share: $2.41 expected
  • Revenue: $31.83 billion expected

Target, which sells a lot of discretionary merchandise such as clothing and home goods, has posted declining comparable sales for two quarters in a row. The industry metric, also called same-store sales, takes out the effect of store openings, closures and renovations. 

The company previously said it anticipated that trend would continue, even during the holiday season. It said in November that it expected comparable sales to drop by around the mid-single-digits in the fiscal fourth quarter and adjusted earnings per share to range between $1.90 and $2.60.

To attract value-focused shoppers, the cheap chic retailer has stressed low prices and higher-frequency categories, such as food and beauty. Over the holiday season, for example, the company emphasized a wide assortment of toys and gifts for under $25. Last month, it launched a new low-priced private brand called Dealworthy, including items such as socks, paper towels, laundry detergent and more, with most items costing under $10.

Compared with big-box rival Walmart, Target has faced another challenge: Groceries make up a smaller part of its business. The category draws foot traffic and steadier sales, even as shoppers cut back in other areas. Grocery drives about 20% of Target’s annual sales compared with nearly 60% of Walmart’s annual sales in the U.S.

Some of Target’s stores are also losing a separate traffic driver: pharmacies. CVS Health said in January that it would close some locations in Target stores, as part of a broader plan by CVS to reduce its store count. CVS and Target declined to say how many of the pharmacies would be shuttered.

Target will hold a financial meeting with investors on Tuesday in New York City.

As of Monday’s close, Target’s shares are up nearly 6% so far this year. That falls short of the approximately 8% gains of the S&P 500 during the same period. Target’s shares closed on Monday at $150.49 apiece, bringing the company’s market value to nearly $70 billion.

This is breaking news. Please check back for updates.



Source

Nike cuts 1,400 roles in second round of layoffs this year
Business

Nike cuts 1,400 roles in second round of layoffs this year

People walk past a Nike store in New York City, on April 2, 2025. Kylie Cooper | Reuters Nike announced a new round of layoffs on Thursday impacting approximately 1,400 roles across the organization, mostly concentrated in its technology department. In a note from COO Venkatesh Alagirisamy, the company said the layoffs were part of […]

Read More
Trump administration moves to reclassify cannabis in major shift that could expand research
Business

Trump administration moves to reclassify cannabis in major shift that could expand research

The Trump administration moved Thursday to reclassify cannabis under federal law, which could significantly expand scientific research into the drug’s medical uses. The change would not legalize the drug at the federal level, but shift cannabis from its current status as a Schedule I substance to Schedule III under the U.S. Drug Enforcement Administration’s controlled […]

Read More
Regeneron inks drug pricing deal with Trump, will offer new hearing-loss therapy for free
Business

Regeneron inks drug pricing deal with Trump, will offer new hearing-loss therapy for free

U.S. President Donald Trump (C) speaks during an event on advancing health care affordability in the Oval Office of the White House on April 23, 2026 in Washington, DC. Alex Wong | Getty Images Regeneron agreed to lower U.S. drug prices for some Americans as part of a deal with President Donald Trump, the White […]

Read More